DIA Biosimilars 2013

CHDI Foundation

Roche, Isis Pharmaceuticals form alliance for Huntington's disease

Monday, April 8, 2013 02:29 PM

Basel, Switzerland-based Roche and Isis Pharmaceuticals of Carlsbad, Calif., have formed an alliance to develop treatments for Huntington's disease (HD) based on Isis' antisense oligonucleotide (ASO) technology.

More... »

Cenduit: Now with Patient Reminders

Evotec, CHDI Foundation extend collaboration in Huntington's

Tuesday, October 30, 2012 12:23 PM

CHDI Foundation, a privately-funded not-for-profit research organization dedicated to developing therapies for Huntington's disease, has extended its collaboration with Evotec, a drug discovery alliance and development partnership company based in Germany, until the end of 2015. The contract extension could be worth up to $41 million in research payments for Evotec.

More... »

CRF Health – eCOA Forum

Galenea, CHDI Foundation expand Huntington's disease collaboration

Friday, August 10, 2012 10:20 AM

Galenea, a Cambridge, Mass.-based company focused on synaptic transmission drug discovery, and CHDI Foundation, a not-for-profit, biomedical research organization focused on Huntington’s disease (HD), have extended and expanded their collaboration to further characterize the synaptic dysfunction apparent in HD utilizing Galenea’s proprietary platform.

More... »

CHDI Foundation selects Greenphire technology for global clinical payment

Friday, June 1, 2012 12:42 PM

CHDI Foundation, a non-profit biomedical research organization focused on Huntington’s disease (HD), will be implementing Philadelphia-based Greenphire’s two flagship payment technology platforms, eClinicalGPS and ClinCard System, to enhance its payment capability in the upcoming Enroll-HD global observational study.

More... »

Lundbeck, CHDI Foundation collaborate on Huntington’s disease

Tuesday, May 22, 2012 10:23 AM

Lundbeck, a pharmaceutical company based in Deerfield, Ill. and CHDI Foundation, a not-for-profit biomedical research organization, have formed a research collaboration to investigate a targeted therapy for Huntington’s disease.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.